RESEARCH TRIANGLE PARK, N.C. August 18, 2010 — Biotechnology business development executive and consultant Peter Ginsberg has joined the North Carolina Biotechnology Center as vice president of Business & Technology Development.
Ginsberg had been consulting with biotech, pharmaceutical and medical device clients since moving to North Carolina from Minnesota, where he’d been vice president of business development and strategic planning at SurModics, a publicly traded leader in the field of drug delivery.
Ginsberg, who reports to Ken Tindall, Ph.D., senior vice president of Science and Business Development, has two decades of healthcare and financial services experience.
“We’re delighted to have someone with Peter’s background and experience to lead this pivotal group,” said Tindall.
“As we move into our next 25 years of international biotechnology leadership, we continue to evolve and create new ways to sustain promising young companies on which North Carolina pins its future. Peter brings a level of expertise that will serve us well going forward.”
Ginsberg said the Biotechnology Center represents a unique opportunity for him to play a role in the growth of a broad array of North Carolina’s emerging biotechnology companies.
“I am honored to join this organization at this point in its history,” he said. “I look forward to working with the great team here to further the Biotechnology Center’s statewide job-creation activities by helping to convert more of North Carolina’s entrepreneurial endeavors and academic spin-outs into successful biotechnology companies.”
Before joining SurModics in 2006, Ginsberg spent three years at Deephaven Capital Management where he was responsible for healthcare equity investments. For six years before that, he was a managing director and senior biotechnology analyst at Piper Jaffray.
He had also served on the faculty of the University of Minnesota’s Carlson School of Management. Additionally, he currently serves on the board of UNC Kenan-Flagler’s Applied Investment Management program and as an Entrepreneur Affiliate at Duke’s Fuqua School of Business.
Ginsberg earned an A.B. in Economics from Princeton University in 1987 and an M.B.A. from the Tuck School of Business at Dartmouth College in 1991.
The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.
